Grifols launches FESILTY fibrinogen concentrate in the US

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. CRWD
2. REGN
3. LITE
4. AAPL
5. ABBV
6. MRVL
7. CL
8. LYB
9. TFII
10. ORCL

Go back to Grifols launches FESILTY fibrinogen concentrate in the US

Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S.

June 15, 2026 8:00 AM EDT

The new fibrinogen concentrate, approved in the U.S. for acute bleeding episodes in pediatric and adult patients with congenital fibrinogen deficiency, is now available in the U.S.

FESILTY complements Grifols bleeding management portfolio, expanding therapeutic options for patients.

BARCELONA, Spain, June 15, 2026 (GLOBE NEWSWIRE) -- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ: GRFS), a global healthcare company and leading producer of plasma-derived medicines, today announced the... More